Home/Pipeline/Generic Advair (Fluticasone/Salmeterol)

Generic Advair (Fluticasone/Salmeterol)

Asthma, COPD

ANDA Filed/ApprovedActiveN/A

Key Facts

Indication

Asthma, COPD

Phase

ANDA Filed/Approved

Status

Active

Company

Lupin Limited

About Lupin Limited

Lupin Limited is a multinational pharmaceutical leader with a mission to catalyze treatments that transform hope into healing, driven by science and a patient-first mindset. The company has achieved global scale with operations in over 100 countries, 15+ manufacturing facilities, and a diversified business spanning generics, complex formulations, APIs, and emerging adjacencies in diagnostics and digital health. Its strategy integrates vertical integration, R&D in complex generics and biosimilars, and expansion into holistic healthcare solutions to drive sustainable growth in both developed and emerging markets.

View full company profile

Therapeutic Areas

Cardiovascular Diabetology Asthma/Respiratory Central Nervous System Gastrointestinal Anti-infectives Pain Management/NSAIDs

Other Asthma, COPD Drugs

Drug	Company	Phase	Status
HBM9378 (SKB378/WIN378)	Harbour BioMed	Phase 1	Active (Greater China)
HP-Betadex DPI Formulations	Aquilon Pharmaceuticals	Clinical	Active
Respiratory Inhalation Portfolio (Generic)	Cipla	ANDA Filed/Approved	Active
Wixela Inhub (Fluticasone/Salmeterol)	Viatris	Launched	Marketed (US, Authorized Generic)
QX008N	Qyuns Therapeutics	Phase 1	Active
RELVAR/BREO ELLIPTA	Innoviva	Commercial	Royalty Revenue Generating